Plasma cholesteryl ester transfer protein (CETP) facilitates the transfer of cholesteryl ester (CE) from high density lipoprotein (HDL) to apolipoprotein
Introduction
Many epidemiological studies have demonstrated a negative correlation of serum high density lipoprotein (HDL) cholesterol levels with the incidence of coronary heart disease (CHD), and subjects with genetic HDL deficiency often have accompanying atherosclerotic car-
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Makoto Nagano 1 (1, 2) . Therefore, HDL plays a crucial role in the protection of blood vessels from atherosclerosis. HDL functions to deliver excess cholesterol from peripheral tissues to the liver for excretion into the bile, a pathway designated as 'reverse cholesterol transport' (3, 4) . In this system, small HDL or free apolipoprotein (apo) A-I removes free cholesterol (FC) from the peripheral cells, and FC in HDL is esterified by lecithin: cholesterol acyltransferase (LCAT) to cholesteryl ester (CE), which is subsequently transferred to very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL) and low density lipoprotein (LDL) by plasma cholesteryl ester transfer protein (CETP) (5-7). IDL and LDL are catabolized via the LDL receptor in the liver. Furthermore, the CE moiety of HDL is taken up selectively by the liver via scavenger receptor class B type I (SR-BI) (8) . Thus, CETP is involved in the regulation of plasma HDL cholesterol levels, and facilitates the remodeling of HDL particles.
The significance of plasma CETP in lipoprotein metabolism was highlighted by the discovery of CETP deficiency with marked hyperalphalipoproteinemia (HALP). Genetic CETP deficiency is the most important and common cause of HALP in the Japanese. In the current review, we will focus on the findings obtained on Japanese CETP deficiency.
CETP gene mutations and their frequency in the Japanese
Human CETP cDNA, cloned by Drayna et al. (9) , encodes a very hydrophobic glycoprotein with an Mr of 74,000, containing 476 amino acid residues (4, 10). The human CETP gene is mapped in chromosome 16 (16q13) near the LCAT gene and spans over 25k base pairs, including 16 exons (11). Since genetic deficiency of CETP activity was first described by Kurasawa et al. and Koizumi et al. in 1985 (12, 13) , to date, genetic CETP deficiency has been the most important and frequent cause of HALP in the Japanese (14) (15) (16) (17) (18) (19) . Ten mutations in the CETP gene have so far been identified Japanese CETP deficiency, including 3 splicing site, 3 nonsense, 1 promoter, and 3 missense mutations (14, 17, 18, (20) (21) (22) (23) (24) (25) (Table 1) . Of the 10 mutations, it has been demonstrated that a G-to-A substitution at the 5' splice donor site of intron 14 (Int14 + 1 G → A) and a missense mutation of exon 15 (D442G) in the CETP gene are common mutations associated with HALP in the Japanese. Furthermore, the prevalences of the Int14 + 1 G → A and D442G mutations are extremely high in the general Japanese population, with heterozygote frequencies of 1% and 7%, respectively (15, 18, 26, 27) . Other mutations are less frequent than the two common mutations in the CETP gene, but 4 mutations including -69 G → A, L151P, G181X and Int14 + 3 T ins have been found in unrelated Japanese subjects with HALP. Some studies including ours have demonstrated that CETP deficiency contributed to about half of HALP subjects in the Japanese (18, (20) (21) (22) . By using the Invader  assay (28) for 9 CETP gene mutations, we studied their frequency among 466 unrelated Japanese subjects (163 men and 303 women) with HALP (HDL cholesterol ≥ 2.07 mmol/l = 80 mg/dl) excluding primary biliary cirrhosis, nephrotic syndrome, thyroid dysfunction and massive alcohol drinkers ( ≥ 80 g/day), and demonstrated that the frequency of CETP deficiency was 61.7% and 31.4% for marked HALP (HDL cholesterol ≥ 2.59 mmol/l = 100 mg/dl) and moderate HALP in the Japanese, respectively ( Fig. 1) (20, 21) .
CETP gene mutations and its functional impairment
Seven mutations including splicing and nonsense mutations are known to be null type mutations of the CETP The position is relative to the GenBank sequence AC010550 with the start of transcription denoted as position +1. NA indicates not applicable.
gene in the Japanese. The homozygous subjects with an Int14 + 1 G → A, G181X, Q182X or G309X mutation had no detectable levels of CETP mass and activity in the plasma (14) (15) (16) (22) (23) (24) . Furthermore, Int10 + 2 T → G and Int14 + 3 T ins mutations are also thought to be null type mutations, because compound heterozygotes with Int14 + 1 G → A had no CETP mass and activity in the plasma (18, 25) . The Int14 + 1 G → A mutation causes exon 14 skipping of mRNA in monocyte-derived macrophages (29) . The exon-skipping deletion causes a frameshift and introduces a premature termination codon downstream at codon 403. It decreases the stability of mRNA and produces a truncated protein that is rapidly degraded intracellularly in the transfected COS-1 cells. These observations clearly explain the molecular basis of the subjects with the common Int14 + 1 G → A splicing mutation but also explain the subjects with the other nonsense mutations that lead to a larger truncation of the carboxyl terminus of CETP. In the Int10 + 2 T → G mutation, which was identified in subjects with the Int14 + 1 G → A mutation, the sequence analysis of CETP mRNA in the proband's monocyte-derived macrophages demonstrated abnormal splicing with the deletion of exon 10 as well as alternative splicing at a native AG site located 31 nucleotides 5' of the normal splice acceptor in intron 13 (25) . Thus, the Int10 + 2 T → G mutation causes exon 10 skipping and the insertion of a 31-bp fragment between exon 13 and exon 14, which contains an inframe stop codon. On the other hand, the L151P mutation is the only missense mutation of the CETP gene, which has a null allelic effect (21) . The CETP mass levels in two subjects with the L151P mutation were similar to those in subjects with the Int14 + 1 G → A mutation. Moreover, no CETP protein was detected in the media of the COS-7 cells transfected with the L151P mutant, although a comparable expression of CETP protein was detectable in the cells. The leucine at codon 151 is likely to be structurally important because this residue is homologously conserved among the lipid transfer/lipopolysaccharide binding protein family members, and located within one of the β-sheets (βB7) in the NH2-terminal domain (30) (31) (32) .
A promoter mutation and 2 other missense mutations identified in the Japanese HALP subjects are thought to cause partial CETP deficiency. The -69 G → A mutation is a G-to-A substitution at the -69 nucleotide of the promoter region, corresponding to the second nucleotide of the PEA3/ETS binding site (CGGAA) located upstream of the putative TATA box (20, 33) . A reporter gene assay has shown that this mutation markedly reduced the transcriptional activities in HepG2 cells (8% of wild type). The importance of the PEA3/ETS binding site in transcriptional regulation has also been supported by Gaudet and Ginsburg (34) . Plasma CETP levels in 6 subjects with the -69 G → A mutation suggested that this mutation might have a null allelic effect rather than partial defi- ciency in vivo. The D442G mutation was first identified in two probands, although heterozygous for this mutation, which had a 3-fold increase in HDL cholesterol and markedly decreased plasma CETP activity and mass (17) . These data suggested that the D442G mutation might have some dominant effects on CETP and HDL in vivo. This was confirmed in vitro by the expression of wild type and mutant proteins in COS-7 cells. Cellular expression of mutant cDNA results in secretion at only 30% of wild type CETP activity. Moreover, co-expression of wild type and mutant cDNA leads to inhibition of the secretion of wild type CETP and activity. However, in the latter studies, the D442G heterozygous subjects had relatively high CETP activity and mass and a wide range of HDL cholesterol levels (18) . Moreover, the specific activity of plasma CETP in the homozygous subjects with the D442G mutation was similar to that of the wild type (21) . Therefore, as the authors explained in the discussion, other unknown factors contributed to the increased HDL in the two probands. The R282C mutation was found in only one compound heterozygote with the D442G mutation, whose plasma CETP levels were significantly lower when compared with those in D442G heterozygous subjects (21) . The mutant CETP showed a marked reduction in the secretion of CETP protein into media from transfected COS-7 cells (39% of wild type). Arginine at codon 282, a positively charged residue, is thought to be in the vicinity of the C-terminal pocket and interacts with the phosphate group of a bound phospholipid (31) . Arginine at codon 282 is likely to be structurally rather than functionally important because the specific activity of the R282C mutant was similar to that of the wild type in the transfection experiment. Table 2 shows the lipid profiles and plasma CETP levels of the HALP subjects with the common CETP gene mutations (HDL cholesterol ≥ 2.07 mmol/l = 80 mg/dl) (20, 21) . The plasma CETP concentrations determined by sandwich ELISA in 211 normolipidemic male subjects and female subjects without the known CETP gene mutations were 1.93 ± 0.50 µg/ml (mean ± SD) and 2.36 ± 0.66 µg/ml, respectively. The plasma CETP mass and activity were not detected in the homozygous subjects with the Int14 + 1 G → A mutation. The subjects with the Table 2 . Lipid profiles and plasma CETP levels in HALP subjects with the common mutations of the CETP gene. Apo E, mg/dl 5.3 ± 1.6* 9.9 ± 4.3** 5.9 ± 2.2** 6.6 ± 2.2** 7.5 ± 2.9** 4.6 ± 0.9 CETP mass, µg/ml heterozygous Int14 + 1 G → A mutation had about half the CETP mass of the normal controls. On the other hand, the CETP concentration in the subjects with the homozygous D442G mutation was 0.72 ± 0.16 µg/ml and 1.23 ± 0.27 µg/ml, for the males and females, respectively, but in the heterozygous subjects was 1.56 ± 0.42 µg/ml and 2.09 ± 0.56 µg/ml, for the males and females, respectively, showing only a mild change (a 17% decrease). The specific activity of plasma CETP in the subjects with the D442G mutation was similar to that in the normolipidemic controls without CETP gene mutations.
Association of plasma CETP levels and lipid profiles with CETP mutations
In each genotype with the common CETP mutations except for the homozygous Int14 + 1 G → A mutation, the mean plasma CETP levels in the male subjects were significantly lower than those of the female subjects. Among the completely CETP-deficient subjects, the homozygous subjects with the Int14 + 1 G → A mutation had markedly elevated levels of HDL cholesterol (3-6-fold increase), while the heterozygous subjects had moderately increased HDL cholesterol levels (12, 13, 15, 16, 18, 20, 21, 35) . The TG levels of the subjects were slightly increased compared with those of the controls. The concentrations of apo A-I, C-II, C-III and E in CETP deficiency were also markedly increased, while the apo B level was normal or slightly decreased. These increases in apo C-III and E are derived from the increment of HDL particles containing apo C-III and E. In subjects with other genotypes of common CETP gene mutations, the plasma HDL cholesterol levels and the concentrations of apo A-I, A-II, C-II, C-III and E were significantly increased, although the difference was not so marked compared with that for the homozygous Int14 + 1 G → A mutation. Among the subjects with two common CETP gene mutations, CETP activity and mass concentration were negatively correlated with plasma HDL cholesterol, apo A-I, A-II, C-II, C-III and E, and positively with plasma LDL cholesterol.
Effect of CETP gene polymorphisms on plasma CETP mass and HDL cholesterol in the heterozygous subjects with common CETP gene mutations
Several common polymorphisms have been reported in the human CETP gene including -629 A/C in promoter region (36) , TaqIB polymorphism in intron 1 (37), MspI in intron 8 (37) and I405V in exon 14 (11). Among these polymorphisms, TaqIB polymorphism has been intensely studied, although the polymorphism is not expected to directly influence CETP transcriptional regulation or RNA splicing but rather to affect CETP gene expression, due to its location in intron 1 (+ 279 G/A). In normolipidemic subjects, the B2 allele (absence of the TaqIB restriction site) at this polymorphism site has been associated with decreased CETP levels and increased HDL cholesterol levels (38) (39) (40) (41) (42) , thus resembling a mild phenotype of CETP deficiency. Moreover, it has been shown that the TaqIB-B2 allele had a dose-dependent association with CHD risk in many studies including the Framingham Offspring Study (43) , although this association may be populationspecific and highly influenced by environmental factors, such as alcohol consumption and smoking.
Our results suggested that the TaqIB-B2 allele is associated with both lower plasma CETP concentrations and higher HDL cholesterol levels in subjects not only without CETP gene mutations, but also with heterozygous CETP deficiency; this association was also observed in the heterozygous subjects with the Int14 + 1 G → A mutation, but not significantly ( Table 3 ). The linkage disequilibrium that we have observed among 4 different polymorphisms and 2 common mutations in the Japanese, the CETP gene splitting into a 5' haplotype block and a 3' haplotype block, is similar to that observed previously in Caucasians (44, 45) . Table 4 summarizes the haplotype based on 4 polymorphisms in homozygous subjects with Int14 + 1 G → A or D442G mutations. The 4 polym o r p h i s m s g e n e r a t e d 8 m a i n h a p l o t y p e s i n normolipidemic subjects without CETP gene mutations. On the other hand, in the homozygous subjects with the Int14 + 1 G → A mutation, all had 1 haplotype, and the homozygous subjects for D442G had 2 main haplotypes. These results seem to be supported by studies investigating the association between common CETP gene mutations and polymorphism(s) (15, 47, 48) . Thus, we determined the haplotypes of the normal allele in the heterozygous subjects with common CETP gene mutations when haplotype analysis was performed. Moreover, there are some haplotypes in the D442G mutation of the CETP gene, and this mutation is frequent in West Asian populations. It is suggested that the D442G mutation originated earlier than the Int14 + 1 G → A mutation.
Recently, Lu et al. investigated in detail the association between promoter polymorphisms and CETP/HDL cholesterol in a sample of 357 elderly Japanese men (49) . Their haplotype analyses indicated that the -2,505 C/A polymorphism (50) and 1,946 VNTR [gaaa]n (51) might explain the variations in the CETP concentrations, and may independently determine the variations in HDL cholesterol levels, whereas the -629 A/C and TaqIB polymorphisms were not instrumental in determining CETP concentrations or HDL cholesterol levels. The importance of 1,946 VNTR for plasma HDL cholesterol was also described by Thompson et al (45) . 1,946 VNTR seems to be significantly associated with CETP/HDL cholesterol, even in heterozygous subjects with common CETP gene mutations.
Lipoprotein abnormalities in homozygous CETP deficiency
In 1984, we described two patients with marked HALP who suffered from angina pectoris and premature cor- neal opacity. We hypothesized that marked HALP is not always beneficial, but can be athergenic (52) . We extensively analyzed lipoproteins from CETP-deficient subjects, and demonstrated that LDL and HDL were abnormal biochemically and biologically. Fig. 2 summarizes the characteristics of plasma lipids and lipoproteins in CETP-deficient subjects homozygous for the Int14 + 1 G → A mutation. The subjects showed extremely high HDL cholesterol and relatively low LDL cholesterol levels. The increase in HDL cholesterol was attributed to the increase in HDL2 cholesterol, while HDL3 cholesterol was not increased. Large and apolipoprotein E-rich HDL particles accumulated in the plasma of the CETP-deficient subjects (53) . HDL particles in CETP deficiency, which are more enriched with CE but poorer in TG than control HDL, had a reduced capacity for inhibiting acetyl LDL-induced accumulation of CE in mouse peritoneal macrophages, and less capacity than normal HDL2 for cholesterol efflux from macrophages preloaded with CE by acetylated LDL (54) . This suggests that large CE-rich HDL2 particles from CETP-deficient subjects do not have an anti-atherogenic function. Two types of HDL particles exist in human plasma: HDL particles containing only apo A-I (LpA-I) and those containing both apo A-I and A-II (LpA-I/A-II). The LpA-I level is low in subjects with CETP deficiency, resulting in a significant decrease in the efflux and LCATmediated esterification of cholesterol (55) . Furthermore, Oliveira et al. demonstrated that the esterification of cholesterol was reduced in subjects with both heterozygous and homozygous CETP deficiency (56) . A stable isotope study demonstrated that the fractional catabolic rates (FCRs) of apo A-I and A-II were significantly reduced in CETP-deficient subjects, whereas the rates of apo A-I and apo A-II production were normal (57) . Thus, homozygous CETP deficiency causes a marked delay in the catabolism of apo A-I and A-II. In contrast, the FCRs of apo B were significantly increased in the subjects, while the production rate of apo B was slightly decreased (58) . However, the LDL particles from CETP-deficient subjects are small and very heterogeneous (polydisperse LDL) and apo B-rich (59, 60) . These particles have a reduced affinity to the LDL receptor of fibroblasts (61) , which may be susceptible to in vivo oxidation (Fig. 2) . In fact, plasma oxidized-LDL is increased in CETP-deficient subjects (62) . Taken together, homozygous CETP deficiency causes functional abnormalities as well as compositional changes in both HDL and LDL. Further analysis is essential to investigate whether heterozygous CETP-deficient subjects have lipoprotein abnormalities similar to those of homozygous CETP-deficient subjects, and to determine the other HDL functions, such as anti-oxidant, anti-thrombotic and anti-inflammatory properties.
Relationship between CETP deficiency and atherosclerosis
Several epidemiological studies in the Japanese have investigated the atherogenicity of CETP deficiency. We found a unique area in the northern part of Japan called Omagari (Akita Prefecture), where a null type mutation, Int14 + 1 G → A, of the CETP gene was present in high frequency (63) . The prevalence of marked HALP and the Int14 + 1 G → A mutation were 10-fold and 20-fold higher in this area than in other areas of Japan, respectively. This discovery provided us with an opportunity to ascertain whether or not marked HALP caused by CETP gene mutation is associated with longevity. The prevalence of both the Int14 + 1 G → A mutation and marked HALP declined with aging. Furthermore, we examined the relationship between HDL cholesterol levels and ischemic ECG changes, showing that the negative correlations which have been demonstrated by numerous epidemiologic studies were observed only in the range of HDL cholesterol < 1.81 mmol/l = 70 mg/dl. In the range of HDL cholesterol ≥ 1.81 mmol/l, the incidence of ischemia was, rather, increased (Fig. 3) . These results show that CETP deficiency is not associated with longevity, but instead may be atherogenic. Recently, we performed the quantification of atherosclerotic areas in CETP deficiency with HDL cholesterol ≥ 2.59 mmol/l. Subjects with any known major risk factors including hypertension, diabetes mellitus, high LDL cholesterol, smoking and obesity were excluded from this study. Parameters tested were plaque score (PS) in the carotid artery and pulse wave velocity (PWV) from the aortic root to the femoral artery. Both PS and PWV were higher in subjects with CETP deficiency, compared with those of age-and sexmatched controls, suggesting that CETP deficiency is substantially atherogenic. Two other epidemiological studies were reported in populations with the D442G missense mutation. One of them was performed in Japanese-American men living in Hawaii (Honolulu Heart Program) (64) , the other in the Japanese population living in Kochi Prefecture, Japan (65) . In 3,496 Japanese-American men living in Hawaii, the incidence of CHD was higher in subjects with the D442G mutation than in those without mutations, although the difference was significant only in subjects whose HDL cholesterol level was between 1.06 and 1.55 mmol/l (40-60 mg/dl). However, men with increased HDL levels ( >1.55 mmol/l) in this population had a low risk of CHD, irrespective of the presence or absence of the CETP gene mutation, appearing to be protected against atherosclerosis. The other study in the Kochi Prefecture demonstrated results similar to those in the Japanese-American men living in Hawaii.
The above data show that CETP deficiency is atherogenic, but that atherogenicity in CETP deficiency is not always correlated with the level of plasma HDL cholesterol. Thus, further analysis is essential for the complete understanding of the atherogenicity of CETP deficiency.
Conclusion
CETP deficiency is the most important and common cause of HALP in the Japanese. Further analysis is essential for the complete understanding of the atherogenicity of human CETP deficiency, especially the heterozygous deficiency. 
